Cabot Corporation
CBT Basic Materials Specialty Chemicals
Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024.
- Revenue
- +12.2%
- EPS
- +79.4%
- Free cash flow
- −51.7%
- Total debt
- +10.8%
Quarter to September 2026, against a year earlier
Follow CBT
Alert me
Cabot Corporation (CBT) Revenue
Cabot Corporation's revenue for fiscal 2025 was $3.7B, down 7.04% from $4.0B in fiscal 2024. Over the twelve months to 30 September 2026 it was $3.7B. Over the past ten years it has ranged from $2.4B (fiscal 2016) to $4.3B (fiscal 2022); the current reading is higher than 73% of that period. Cabot Corporation ranks 19th of 58 Specialty Chemicals companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $3.7B | (7.04%) |
| FY2024 | $4.0B | 1.60% |
| FY2023 | $3.9B | (9.03%) |
| FY2022 | $4.3B | 26.75% |
| FY2021 | $3.4B | 30.41% |
| FY2020 | $2.6B | (21.67%) |
| FY2019 | $3.3B | 2.93% |
| FY2018 | $3.2B | 19.32% |
| FY2017 | $2.7B | 12.69% |
| FY2016 | $2.4B | (16.02%) |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $1.0B | 2.75% |
| Jun 2026 | $982.0M | 8.63% |
| Mar 2026 | $904.0M | 6.48% |
| Dec 2025 | $849.0M | (5.56%) |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| CLMT Calumet, Inc. compare | $4.6B |
| CBT Cabot Corporation | $3.7B |
| FUL H. B. Fuller Company compare | $3.6B |
| AVNT Avient Corporation compare | $3.4B |
| ASH Ashland Inc. compare | $1.9B |
| SXT Sensient Technologies Corporation compare | $1.7B |
| HWKN Hawkins, Inc. compare | $1.1B |
| PRM Perimeter Solutions, SA compare | $831.5M |
| WDFC WD-40 Company compare | $688.0M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on CBT
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement